Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fievet

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Transgenic rabbits expressing human apolipoprotein A-I in the liverN Duverger, C Viglietta, L Berthou, et al.
Circulation Research|October 16, 1999
Protective role of interleukin-10 in atherosclerosisZ Mallat, S Besnard, M Duriez, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
The Journal of Biological Chemistry|June 26, 2001
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1R R Singaraja, V Bocher, E R James, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Transgenic rabbits expressing human apolipoprotein A-I in the liverN Duverger, C Viglietta, L Berthou, et al.
Circulation Research|October 16, 1999
Protective role of interleukin-10 in atherosclerosisZ Mallat, S Besnard, M Duriez, et al.
Molecular Pharmacology|February 13, 2001
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activityP J Davies, S A Berry, G L Shipley, et al.
The Journal of Biological Chemistry|June 26, 2001
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1R R Singaraja, V Bocher, E R James, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2022
Effectiveness and safety of dupilumab in the treatment of atopic dermatitis in children (6-11 years): data from a French multicentre retrospective cohort in daily practiceA Lasek, N Bellon, S Mallet, et al.
Pageof 7